What CART-Tech does

CART-Tech is a privately held medical technology company headquartered in Utrecht, the Netherlands, founded in 2014. According to its firmographic profile, the company develops an image-guided technology device for cardiac resynchronization therapy (CRT), a treatment used in patients with heart failure to synchronize ventricular contractions via an implantable device. The implied clinical value proposition is to improve the precision of CRT lead placement or patient selection through image guidance, which is a recognized challenge in the field. The company is led by co-founder and Chief Executive Officer Paul Leufkens.

The organization operates at very small scale, with a headcount reported as 1-10 employees, consistent with an early-stage medical device venture. No products have been publicly catalogued, no pricing or revenue model has been disclosed, and the company website (cart-tech.com) currently presents only a loading/verification page with no substantive product, regulatory, or operational information. There are no recorded funding rounds, acquisitions, partnerships, certifications, patents, or named customers in the available source data, indicating that CART-Tech has not yet achieved visible commercial or regulatory milestones in public records.

Given the absence of disclosed commercialization signals, the company most likely remains in a research, prototyping, or pre-clinical/pre-commercial stage of development. The narrow technical focus on image-guided CRT positions CART-Tech in the cardiology medtech subsegment, addressing a real procedural challenge but competing in a space dominated by large incumbents (Medtronic, Abbott, Boston Scientific, Biotronik). Investors evaluating CART-Tech should treat the available data set as severely information-constrained and weight diligence toward regulatory pathway, IP estate, clinical evidence, and management track record accordingly.

Name

CART-Tech

Website

https://cart-tech.com

Company type

Private

Founded year

2014

Headcount range

1–10 employees

Short description

CART-Tech is a Utrecht-based medical technology company founded in 2014 that develops an image-guided technology device for cardiac resynchronization therapy. The privately held firm, led by CEO and co-founder Paul Leufkens, operates with fewer than 10 employees.

Ownership category

akta.pro rank

Product category

Cardiac Resynchronization Therapy Devices

NAICS

Scientific Research and Development Services (5417)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Cardiac Rhythm Management (Pacemakers, ICDs, CRT) (HLAHAFAC)

Keywords

• Cardiac resynchronization therapy
• Image-guided medical devices
• Heart failure treatment
• Cardiac intervention technology
• Electrophysiology devices

Headquarters

HQ city

Utrecht

HQ country

Netherlands

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain

Core offering

CART-Tech develops an image-guided technology device used during cardiac resynchronization therapy (CRT), a treatment for patients with heart failure. The device supports clinicians by providing image-guided navigation to improve the placement and delivery of CRT therapy.

Differentiator

Problem solved

Functional benefit

Products and services

• Image-guided CRT device

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Broad incumbents

• Medtronic: Global leader in cardiac rhythm management with extensive CRT-D and CRT-P product lines and deep clinical relationships. Comparable as the dominant incumbent CART-Tech would need to displace or partner with.
• Abbott: Major CRT device manufacturer (Gallant, Quadra Assura families) with full electrophysiology portfolio. Comparable as an incumbent competitor and potential strategic acquirer in the same clinical procedure.
• Boston Scientific: Sells CRT-D systems and is investing in next-generation pacing including conduction system pacing. Comparable as a leading CRT incumbent competing for the same hospital accounts.
• LivaNova: Medical device company with a cardiac surgery and neuromodulation portfolio including cardiac support technologies. Comparable as an established cardiac-focused device manufacturer addressing similar patient populations.

Direct peers

• Biotronik: Germany-based specialist in cardiac rhythm management with a focused CRT product line. Most directly comparable in scale and CRT-only focus, making it the closest head-to-head competitor.
• MicroPort CRM: Cardiac rhythm management division of MicroPort focused on pacemakers and CRT-D devices. Comparable as a focused CRT manufacturer serving similar cardiology customers.

Emerging players

• EBR Systems: Developer of the WiSE wireless cardiac stimulation system for CRT, an alternative-leadless approach. Comparable as a small, venture-stage company pursuing novel CRT technology that competes for clinical mindshare.
• Newronika: Italy-based developer of adaptive neuromodulation technology with potential cardiac applications. Comparable as a small European medical-device innovator pursuing sensing/closed-loop approaches in cardiac care.
• BackBeat Medical: Developer of novel pacing-based therapies for hypertension and heart failure, overlapping CRT clinical indications. Comparable as a venture-stage company pursuing device-based heart-failure therapy innovation.
• CorVista Health: Cardiac diagnostic company applying signal processing and machine learning to heart failure and structural heart disease. Comparable as a small company applying novel technology to the cardiac care continuum that CRT also addresses.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/cart-tech-b.v.

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CART-Tech